Goodrx Holdings Inc at Barclays Global Technology, Media and Telecommunications Conference (Virtual) Transcript
All right. Hello, everyone. Welcome to the next session here at the Barclays TMT Conference. I'm Steven Valiquette, the health care technology analyst here at Barclays. Next company up here is GoodRx, which I co-cover with Ross Sandler.
With us from the management are Doug Hirsch, who is the Co-Founder and Co-CEO; as well as Karsten Voermann, the company's CFO. This will be a fireside chat, where Ross and I will take turns asking a few questions at a time. But before we do that, I'm going to turn it over to Whitney Notaro from Investor Relations at GoodRx just to read some disclosures. So Whitney, over to you.
Steve, Ross, thank you so much for having us today. Before we begin, I just want to remind the audience that this webcast may contain forward-looking statements pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Any forward-looking statements are based on management's
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
